Literature DB >> 32167397

The impact of cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i) on the incidence of alopecia in patients with metastatic breast cancer (BC).

Daniel Eiger1, Marcio Wagner2, Noam F Pondé3, Melanie S Nogueira4, Laurence Buisseret1, Evandro de Azambuja1.   

Abstract

Entities:  

Year:  2020        PMID： 32167397     DOI： 10.1080/0284186X.2020.1738547

Source DB:  PubMed          Journal:  Acta Oncol        ISSN： 0284-186X            Impact factor:   4.089


× No keyword cloud information.
  2 in total

Review 1.  Emerging Skin Toxicities in Patients with Breast Cancer Treated with New Cyclin-Dependent Kinase 4/6 Inhibitors: A Systematic Review.

Authors:  Martina Silvestri; Antonio Cristaudo; Aldo Morrone; Claudia Messina; Luigi Bennardo; Steven Paul Nisticò; Maria Mariano; Norma Cameli
Journal:  Drug Saf       Date:  2021-05-06       Impact factor: 5.606

2.  Vitiligo-Like Lesions in a Patient with Metastatic Breast Cancer Treated with Cyclin-Dependent Kinase (CDK) 4/6 Inhibitor: A Case Report and Literature Review.

Authors:  Baha' Sharaf; Rama AlMasri; Nayef Abdel-Razeq; Osama Salama; Ibrahim Hamad; Mahmoud Abunasser; Hikmat Abdel-Razeq
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-01-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.